Head and neck cancer is a blanket term used to describe several different types of cancers.
About 65,000 new cases, not counting thyroid cancer, are diagnosed in the U.S. every year.
A number of causes of these cancers have been identified, potentially offering new
opportunities to screen for the cancers and create new treatments for patients.

For example, the incidence of head and neck squamous cell carcinoma in people with
Fanconi anemia is 500- to 700-fold higher than in the general population. Additionally up to
70% of certain head and neck cancers are caused by human papillomavirus (HPV) infection.
Genetic defects that cause Fanconi anemia, as well as genetic changes resulting from HPV
infection, both adversely affect DNA repair systems, which can lead to cancer. This similarity
provides investigators with different perspectives on a common problem and the opportunity
to collaborate in new and innovative ways.

Head and neck cancers can appear in the nasal cavity, sinuses, lips, mouth, salivary glands,
thyroid gland, throat or larynx. Experts estimate there are about 550,000 cases of various
kinds of head and neck cancer diagnosed around the world each year, with 300,000 annual
deaths due to the cancers. Research has also shown that Black people have higher
incidence of head and neck cancer and a lower 5-year survival rate compared to white
people. Black patients are also typically diagnosed with more advanced head and neck
cancer.

To unlock potential new treatments, Stand Up To Cancer, with the generous support of the
Fanconi Anemia Research Fund, the Farrah Fawcett Foundation, the American Head and
Neck Society, and the Head and Neck Cancer Alliance, is offering up to $3.25 million in
grants to fund research to find new treatments for head and neck cancer. The team will have
a special focus on head and neck cancers associated with Fanconi anemia and HPV. Applicants will need to ensure that people from medically disadvantaged backgrounds are included in all phases of their proposed research.

Further information and a link to the application

visit StandUpToCancer.org/HeadandNeck.

To Reconstruct or Not: Early Stage Oral Cavity Cancers

AHNS Virtual Education Series: To Reconstruct or Not: Early Stage Oral Cavity Cancers

The AHNS gratefully acknowledges support of this webinar from KLS Martin.

Date: Tuesday, February 23, 2021

Time: 4:00 PM Pacific /6:00 PM Central / 7:00 PM Eastern

This session is an hour long

Complimentary to all attendees

Register Here

Faculty:

Host: Urjeet Patel, MD, FACS, Cook County Hospital Stroger

Moderator: Matthew Old, MD, FACS, Wexner Medical Center, The Ohio State University

Panelists:
Alice Lin, MD, FACS, Kaiser Permanente – Los Angeles Medical Center
Larissa Sweeny, MD, Louisiana State University at New Orleans
Neal Futran, MD, Univ of Washington Med Center
Stephan Kang, MD, The Ohio State University
Rizwan Aslam, MD, Tulane University
Rodrigo Bayon, MD, FACS, University of Iowa Hospitals & Clinics
Arnaud Bewley, MD, University of California – Davis Medical Center
Steven Chinn, MD MPH FACS, University of Michigan
Michael Moore, MD, Indiana University School of Medicine
Jason Rich, MD, Washington University School of Medicine
Chad Zender, MD, FACS, University of Cincinnati College of Medicine

Myers’ Family Diversity Summer Travel Fellowship in Otolaryngology for under-represented minority medical students 

Head and neck cancer is a blanket term used to describe several different types of cancers. About 65,000 new cases, not counting thyroid cancer, are diagnosed in the U.S. every year. A number of causes of these cancers have been identified, potentially offering new opportunities to screen for the cancers and create new treatments for patients.

For example, the incidence of head and neck squamous cell carcinoma in people with Fanconi anemia is 500- to 700-fold higher than in the general population. Additionally up to 70% of certain head and neck cancers are caused by human papillomavirus (HPV) infection. Genetic defects that cause Fanconi anemia, as well as genetic changes resulting from HPV infection, both adversely affect DNA repair systems, which can lead to cancer. This similarity provides investigators with different perspectives on a common problem and the opportunity to collaborate in new and innovative ways.

Head and neck cancers can appear in the nasal cavity, sinuses, lips, mouth, salivary glands, thyroid gland, throat or larynx. Experts estimate there are about 550,000 cases of various kinds of head and neck cancer diagnosed around the world each year, with 300,000 annual deaths due to the cancers. Research has also shown that Black people have higher incidence of head and neck cancer and a lower 5-year survival rate compared to white people. Black patients are also typically diagnosed with more advanced head and neck cancer.

To unlock potential new treatments, Stand Up To Cancer, with the generous support of the Fanconi Anemia Research Fund, the Farrah Fawcett Foundation, the American Head and Neck Society, and the Head and Neck Cancer Alliance, is offering up to $3.25 million in grants to fund research to find new treatments for head and neck cancer. The team will have a special focus on head and neck cancers associated with Fanconi anemia and HPV. Applicants will need to ensure that people from medically disadvantaged backgrounds are included in all phases of their proposed research.

Further information and a link to the application visit StandUpToCancer.org/HeadandNeck.

The 2022 Fellowship Match Application is Open

The AHNS currently accredits over 60 fellowship positions from 50 surgical programs in the U.S. and Canada. The application period has begun for fellowships commencing in July of 2022 – the application timeline is as follows:

Application Period: January 15, 2021 – March 1, 2021

Interview Period: March 1, 2021 – June 30, 2021

Ranking list opens for Programs and Applicants: July 1 – 12, 2021

Match results announced: Friday, July 16, 2021

For further information about the fellowships,
please visit the AHNS Website.

Start Your FY2022 Fellowship Application Now

If you have any questions about the online application, the participating programs or the process in general, please contact JJ Jackman in the AHNS Administrative Office at 310-437-0559 x154 or by email at [email protected].